Bank Of New York Mellon Corp Axogen, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$7.53 - $10.95 $991,535 - $1.44 Million	131,678 New	131,678 $1.24 Billion
Q4 2022 Feb 14, 2023	BUY	$9.44 - $13.09 $1.28 Million - $1.77 Million	135,441 New	135,441 $1.35 Million
Q3 2022 Nov 14, 2022	BUY	$8.14 - $12.25 $99,063 - $149,082	12,170 Added 9.73%	137,308 $1.64 Million
Q2 2022 Aug 15, 2022	BUY	$6.99 - $10.0 $27,330 - $39,100	3,910 Added 3.23%	125,138 $1.03 Million
Q1 2022 May 11, 2022	BUY	$7.26 - $10.7 $3,506 - $5,168	483 Added 0.4%	121,228 $962,000
Q4 2021 Feb 11, 2022	BUY	$8.8 - $16.0 $22,959 - $41,744	2,609 Added 2.21%	120,745 $1.13 Million
Q3 2021 Nov 12, 2021	BUY	$15.23 - $21.72 $115,976 - $165,397	7,615 Added 6.89%	118,136 $1.87 Million
Q2 2021 Aug 11, 2021	SELL	$17.8 - $23.5 $405,608 - $535,494	-22,787 Reduced 17.09%	110,521 $2.39 Million
Q1 2021 May 13, 2021	SELL	$17.18 - $22.6 $111,154 - $146,222	-6,470 Reduced 4.63%	133,308 $2.7 Million
Q4 2020 Feb 09, 2021	SELL	$11.5 - $17.96 $44,562 - $69,595	-3,875 Reduced 2.7%	139,778 $2.5 Million
Q3 2020 Nov 12, 2020	SELL	$10.62 - $13.12 $3.79 Million - $4.69 Million	-357,307 Reduced 71.32%	143,653 $1.67 Million
Q2 2020 Aug 12, 2020	SELL	$7.35 - $10.81 $2.37 Million - $3.48 Million	-322,094 Reduced 39.13%	500,960 $4.63 Million
Q1 2020 May 06, 2020	SELL	$8.38 - $17.34 $442,220 - $915,049	-52,771 Reduced 6.03%	823,054 $8.56 Million
Q4 2019 Feb 14, 2020	SELL	$11.18 - $18.6 $1.36 Million - $2.26 Million	-121,520 Reduced 12.18%	875,825 $15.7 Million
Q3 2019 Nov 07, 2019	SELL	$12.09 - $20.46 $1.3 Million - $2.2 Million	-107,638 Reduced 9.74%	997,345 $12.4 Million
Q2 2019 Aug 12, 2019	BUY	$18.5 - $25.47 $510,896 - $703,379	27,616 Added 2.56%	1,104,983 $21.9 Million
Q1 2019 May 14, 2019	SELL	$14.62 - $22.13 $2.16 Million - $3.26 Million	-147,460 Reduced 12.04%	1,077,367 $22.7 Million
Q4 2018 Feb 11, 2019	BUY	$17.09 - $38.25 $2.08 Million - $4.66 Million	121,856 Added 11.05%	1,224,827 $25 Million
Q3 2018 Nov 09, 2018	BUY	$34.05 - $55.9 $6.81 Million - $11.2 Million	199,885 Added 22.13%	1,102,971 $0
Q2 2018 Aug 06, 2018	BUY	$36.15 - $52.5 $930,790 - $1.35 Million	25,748 Added 2.93%	903,086 $45.4 Million
Q1 2018 May 15, 2018	BUY	$24.4 - $40.25 $667,218 - $1.1 Million	27,345 Added 3.22%	877,338 $32 Million
Q4 2017 Feb 09, 2018	BUY	$18.5 - $28.6 $15.7 Million - $24.3 Million	849,993	849,993 $24.1 Million

Others Institutions Holding AXGN

# of Institutions

162

Shares Held

36.6M

Call Options Held

230K

Put Options Held

400

First Light Asset Management, LLC Edina, MN

4.09M
Shares

$67.4 Million
5.0% of portfolio
Black Rock Inc. New York, NY

3.25M
Shares

$53.6 Million
0.0% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

3.01M
Shares

$49.6 Million
3.58% of portfolio
Morgan Stanley New York, NY

2.9M
Shares

$47.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.43M
Shares

$40 Million
0.0% of portfolio

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $697M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account